Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 31, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 1, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 1, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 3, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 3, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 3, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 22, 2003View HTMLDownload DOCDownload PDF
3/AAmendment to a previously filed Form 3.Jul 29, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 29, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 28, 2003View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Jul 28, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 25, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 24, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 22, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 22, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 21, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 17, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 17, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 16, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 15, 2003View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 14, 2003View HTMLDownload DOCDownload PDF

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information